Table 3

Antifungal susceptibility profile of oral Candida isolates from AIDS patients, northwest Ethiopia, 2008/09
Species/Antifungal agent MIC (μ/ml) SDD R: n (%)
MIC Range MIC50 MIC90
All isolates (90)
 Fluconazole 0.125–64 0.25 2 3 (3.3) 11 (12.2)
 Ketoconazole 0.016–16 2 4 - 7 (7.7)
 Itraconazole 0.016–16 0.016 0.063 3 (3.3) 4 (4.7)
 Amphotericin B 0.125– 8 0.125 0.125 - 3 (3.5)
 5-Fuorocytosine 0.125–16 0.125 0.125 - 2 (2.3)
 Micafungin 0.015–8 0.06 1.2 - 2 (2.3)
C. albicans (25)
 Fluconazole 0.125–64 0.25 2 1 (4) 4 (16)
 Ketoconazole 0.016–16 - 3 (12)
 Itraconazole 0.016–16 0.016 0.063 3 (12) 2 (8)
 Amphotericin B 0.125–8 0.5 0.5 - 1 (4)
 5-Fuorocytosine 0.125–16 - - - 1 (4)
 Micafungin 0.015–8 - - - 1 (4)
C. glabrata (25)
 Fluconazole 0.125–64 0.25 2 1 (6) 3 (8)
 Ketoconazole 0.016–16 - - - 1 (4)
 Itraconazole 0.016–16 0.016 0.063 2 (12) 1 (4)
 Amphotericin B 0.125–8 0.5 - - -
 5-Fuorocytosine 0.125–16 - - - 1 (4)
 Micafungin 0.015–8 - - - -
C. tropicalis (25)
 Fluconazole 0.125–64 0.25 2 - 2 (8)
 Ketoconazole 0.016–16 - 1 (4)
 Itraconazole 0.016–16 0.016 0.063 2 (12) 1 (4)
 Amphotericin B 0.125–8 0.5 0.5 - -
 5-Fuorocytosine 0.125–16 - - - 1 (4)
 Micafungin 0.015–8 - - - -
C. krusei (10)
 Fluconazole 0.125–64 0.25 2 1 (10) 1 (10)
 Ketoconazole 0.016–16 - - - 1 (10)
 Itraconazole 0.016–16 0.016 0.063 1 (10) -
 Amphotericin B 0.125–8 0.5 - - -
 5-Fuorocytosine 0.125–16 - - - -
 Micafungin 0.015–8 - - - -
Other Candida species* (5)
 Fluconazole 0.125–64 0.25 2 - 1 (20)
 Ketoconazole 0.016–16 - - - 1 (20)
 Itraconazole 0.016–16 0.016 0.063 1 (10) -
 Amphotericin B 0.125–8 - - - -
 5-Fuorocytosine 0.125–16 - - - -
 Micafungin 0.015–8 - - - -

*: Unidentified Candida species.

Mulu et al.

Mulu et al. BMC Infectious Diseases 2013 13:82   doi:10.1186/1471-2334-13-82

Open Data